Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
VahatiCor Secures $23M Series B to Advance Cardiac Care Technology
Series BVenture Capital

VahatiCor Secures $23M Series B to Advance Cardiac Care Technology

•November 18, 2025
•Nov 18, 2025
0

Participants

VahatiCor

VahatiCor

company

S3 Ventures

S3 Ventures

investor

Intuitive Surgical

Intuitive Surgical

investor

Why It Matters

The funding fast‑tracks development of the only dedicated treatment for CMD, opening a sizable unmet market and offering a therapeutic option for patients who currently have none, while underscoring strong investor confidence in cardiovascular innovation.

Deal Summary

VahatiCor announced the closing of a $23 million Series B round led by S3 Ventures with participation from Intuitive Ventures and a strategic investor. The funding will support enrollment in the SERRA‑I trial, engineering development, and preparation for pivotal studies and regulatory interactions.

0

Comments

Want to join the conversation?

Loading comments...